Contribute Try STAT+ Today

Seeking to reduce a rising tide of shortages, the Food and Drug Administration is considering the idea of creating a system to rate manufacturing facilities run by drug makers.

The hope is that customers — notably, group purchasing organizations for hospitals, but also consumers — would reward drug companies that consistently make medicines that conform to quality standards. In doing so, this could yield steady sales that would, in turn, provide incentives for further investment in facilities and, hopefully, lessen the likelihood of the sorts of quality issues that lead to shortages.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.